Alpine Immune Sciences, Inc.(Deutsche Boerse AG : NVLS)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.88% | 93.92 | 1.3% | $988.55m | |
| BIIB | Biogen Inc. | 2.45% | 229.89 | 1.3% | $619.18m | |
| AMGN | Amgen Inc. | 1.22% | 180.48 | 1.3% | $474.61m | |
| GILD | Gilead Sciences, Inc. | 2.13% | 64.14 | 0.9% | $448.87m | |
| ILMN | Illumina, Inc. | 1.49% | 319.20 | 3.5% | $295.43m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.80% | 349.99 | 2.6% | $291.08m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.18% | 174.61 | 1.9% | $236.35m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 4.30% | 135.68 | 2.0% | $176.60m | |
| EXAS | Exact Sciences Corporation | 0.27% | 95.39 | 25.3% | $169.11m | |
| A | Agilent Technologies, Inc. | 1.23% | 76.72 | 1.6% | $147.38m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.74% | 120.22 | 14.7% | $129.47m | |
| ONCE | Spark Therapeutics, Inc. | 0.64% | 111.38 | 11.2% | $116.56m | |
| INCY | Incyte Corporation | 0.57% | 73.94 | 2.5% | $97.68m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.72% | 73.86 | 8.3% | $96.82m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.21% | 85.31 | 4.3% | $92.88m |
Company Profile
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.